Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC

NCT05059327 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Tuberous Sclerosis Complex

Interventions

DRUG: Basimglurant with crossover to Placebo
DRUG: Placebo with crossover to Basimglurant

Sponsor

Noema Pharma AG